EURAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eurax, and when can generic versions of Eurax launch?
Eurax is a drug marketed by Journey and is included in two NDAs.
The generic ingredient in EURAX is crotamiton. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the crotamiton profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EURAX?
- What are the global sales for EURAX?
- What is Average Wholesale Price for EURAX?
Summary for EURAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Patent Applications: | 3,577 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EURAX |
DailyMed Link: | EURAX at DailyMed |
![EURAX drug patent expirations Drug patent expirations by year for EURAX](/p/graph/s/t/EURAX-patent-expirations.png)
![Drug Prices for EURAX](/p/graph/drug-price/EURAX.png)
![Drug Sales Revenue Trends for EURAX](/p/graph/drug-sales-revenues/EURAX.png)
US Patents and Regulatory Information for EURAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journey | EURAX | crotamiton | CREAM;TOPICAL | 006927-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Journey | EURAX | crotamiton | LOTION;TOPICAL | 009112-003 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |